highly significantp<0.001
MRI positivity was present in 36 (72%) of the treatment-resistant cases in the present study, and this rate was highly significant compared to the drug-responsive cases (p<0.001).
MRI positivity was present in 36 (72%) of the treatment-resistant cases in the present study, and this rate was highly significant compared to the drug-responsive cases (p<0.001).